Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Subanesthetic esketamine PCIA for acute pain and anxiety in emergency trauma patients
ChiCTR2300077248Phase 4Not yet recruiting
- Sponsor
- Xuzhou Central Hospital
- Start
- Sep 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of esketamine, tramadol and acetaminophen in acute pain and anxiety disorder (2 arms), sponsored by Xuzhou Central Hospital. Primary endpoint: Pain score. Planned start Sep 2023; status: not yet recruiting.
02
Drugs
esketaminetramadolacetaminophen
03
Conditions
acute painanxiety disorder
Beyond the preview
Go deeper on ChiCTR2300077248.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300077248.